1. Acute renal failure and death following sequential intermediate dose methotrexate and 5-FU;M, Ellison N.; J, Servi R.;Cancer Treat Reports,1985
2. Renal insufficiency in patients treated with high dose methotrexate;G, Maiche A.; K, Lappalainen; L, Teerenhovi;Acta Oncol,1988
3. Severe toxicity due to intermediate-dose methotrexate;Stark, A.; Jackson, G.; Carey, P.; Arfeen, S.; Proctor, S.;Cancer Chemother Pharmacol,1989
4. Aspirin alters methotrexate disposition in rheumatoid arthritis patients;F, Stewart C.; A, Fleming R.; F, Germain B.; J, Seleznick M.; E, Evans W.;Arthritis Rheum,1991
5. Estimation of technetium 99m mercaptoacetyltriglycerine plasma clearance by use of one single plasma sample;Muller-Suur, R.; Magnusson, G.; Bois-Svensson, I.; Jansson, B.;Eur J Nucl Med,1991